Transitioning Virtual-Only Group Therapy for Substance Use Disorder Patients to a Hybrid Model.

Tyler S Oesterle, Nicholas L Bormann, Domenic A Ochal, Stephan Arndt, Scott A Breitinger
Author Information
  1. Tyler S Oesterle: Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA. ORCID
  2. Nicholas L Bormann: Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA. ORCID
  3. Domenic A Ochal: Mayo Clinic Alix School of Medicine, Rochester, MN, USA.
  4. Stephan Arndt: Department of Psychiatry, University of Iowa, Iowa City, IA, USA.
  5. Scott A Breitinger: Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.

Abstract

Purpose: Telehealth is associated with a myriad of benefits; however, little is known regarding substance use disorder (SUD) treatment outcomes when participants join group therapy sessions in a combination in-person and virtual setting (hybrid model). We sought to determine if treatment completion rates differed.
Patients and Methods: Policy changes caused by the COVID-19 pandemic created a naturalistic, observational cohort study at seven intensive outpatient (IOP) programs in rural Minnesota. Virtual-only delivery occurred 6/1/2020-6/30/2021, while hybrid groups occurred 7/1/2021-7/31/2022. Data was evaluated retrospectively for participants who initiated and discharged treatment during the study period. Participants were IOP group members 18 years and older who had a SUD diagnosis that both entered and discharged treatment during the 26-month period. A consecutive sample of 1502 participants (181-255 per site) was available, with 644 removed: 576 discharged after the study conclusion, 49 were missing either enrollment or discharge data, 14 transferred sites during treatment, and 5 initiated treatment before the study initiation. Helmert contrasts evaluated the impact of hybrid group exposure.
Results: A total of 858 individuals were included. Data was not from the medical chart and was deidentified preventing specific demographics; however, the overall IOP sample for 2020-2022, from which the sample was derived, was 29.8% female, and 64.1% were 18-40 years of age. For completed treatment, hybrid group exposure relative to virtual-only had a univariate odds ratio of 1.88 (95% CI: 1.50-2.41, p < 0.001). No significant difference was seen across IOP sites.
Conclusion: These results describe a novel hybrid group approach to virtual care for SUDs with outcome data not previously documented in the literature. While virtual treatment delivery can increase access, these results suggest a benefit is derived from including an in-person option. Further research is needed to identify how an in-person component may change dynamics and if it can be replicated in virtual-only models.

Keywords

References

  1. Psychotherapy (Chic). 2018 Dec;55(4):316-340 [PMID: 29792475]
  2. Clin Psychol Rev. 2013 Dec;33(8):1010-24 [PMID: 24029221]
  3. Mayo Clin Proc. 2020 Dec;95(12):2709-2718 [PMID: 33276843]
  4. J Health Soc Behav. 1997 Jun;38(2):177-90 [PMID: 9212538]
  5. Mhealth. 2020 Apr 05;6:13 [PMID: 32270005]
  6. J Med Ethics. 2020 Nov 11;: [PMID: 33177147]
  7. MMWR Morb Mortal Wkly Rep. 2020 Sep 11;69(36):1250-1257 [PMID: 32915166]
  8. Int J Drug Policy. 2016 Feb;28:1-9 [PMID: 26790691]
  9. Am J Addict. 2021 Sep;30(5):445-452 [PMID: 34405475]
  10. J Affect Disord. 2014 Feb;155:49-58 [PMID: 24238951]
  11. Harv Rev Psychiatry. 2004 Nov-Dec;12(6):339-50 [PMID: 15764469]
  12. Prim Care. 2022 Dec;49(4):517-530 [PMID: 36357058]
  13. Am J Psychiatry. 1995 Nov;152(11 Suppl):1-59 [PMID: 7485655]
  14. Addict Behav. 2016 Jul;58:129-35 [PMID: 26925821]
  15. Drug Alcohol Depend. 2019 Aug 1;201:227-235 [PMID: 31254749]
  16. J Med Internet Res. 2010 Dec 19;12(5):e74 [PMID: 21169177]
  17. Subst Abuse Treat Prev Policy. 2021 Jun 21;16(1):51 [PMID: 34154619]
  18. J Addict Behav Ther Rehabil. 2013 May 27;2(2): [PMID: 25401117]
  19. JMIR Ment Health. 2022 May 2;9(5):e36775 [PMID: 35499910]

Word Cloud

Created with Highcharts 10.0.0treatmentgrouphybridstudyIOPparticipantsin-personvirtualdischargedsamplehoweverSUDdeliveryoccurredDataevaluatedinitiatedperiodyearsdatasitesexposurederivedvirtual-only1resultscareoutcomecanPurpose:TelehealthassociatedmyriadbenefitslittleknownregardingsubstanceusedisorderoutcomesjointherapysessionscombinationsettingmodelsoughtdeterminecompletionratesdifferedPatientsMethods:PolicychangescausedCOVID-19pandemiccreatednaturalisticobservationalcohortsevenintensiveoutpatientprogramsruralMinnesotaVirtual-only6/1/2020-6/30/2021groups7/1/2021-7/31/2022retrospectivelyParticipantsmembers18olderdiagnosisentered26-monthconsecutive1502181-255persiteavailable644removed:576conclusion49missingeitherenrollmentdischarge14transferred5initiationHelmertcontrastsimpactResults:total858individualsincludedmedicalchartdeidentifiedpreventingspecificdemographicsoverall2020-2022298%female641%18-40agecompletedrelativeunivariateoddsratio8895%CI:50-241p<0001significantdifferenceseenacrossConclusion:describenovelapproachSUDspreviouslydocumentedliteratureincreaseaccesssuggestbenefitincludingoptionresearchneededidentifycomponentmaychangedynamicsreplicatedmodelsTransitioningVirtual-OnlyGroupTherapySubstanceUseDisorderPatientsHybridModelcomparativepsychotherapyhealthassessmentsubstance-relateddisorderstelemedicine

Similar Articles

Cited By (2)